Delhi Court Blocks Ranbaxy Generic Of Novartis Diabetes Drug
This article was originally published in PharmAsia News
Executive Summary
India's Delhi high court issued a restraining order against Ranbaxy Laboratories, preventing it from making and marketing a generic of the Novartis diabetes drug, Galvus (vildagliptin).